Compare ZURA & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | TREE |
|---|---|---|
| Founded | 2022 | 1996 |
| Country | United States | United States |
| Employees | N/A | 926 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 393.5M |
| IPO Year | 2021 | 2008 |
| Metric | ZURA | TREE |
|---|---|---|
| Price | $3.96 | $27.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $19.00 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 4.7M | 230.7K |
| Earning Date | 10-27-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 443.31 |
| EPS | N/A | ★ 1.90 |
| Revenue | N/A | ★ $1,117,324,000.00 |
| Revenue This Year | N/A | $17.25 |
| Revenue Next Year | N/A | $6.95 |
| P/E Ratio | ★ N/A | $14.71 |
| Revenue Growth | N/A | ★ 24.12 |
| 52 Week Low | $3.25 | $23.50 |
| 52 Week High | $7.25 | $68.93 |
| Indicator | ZURA | TREE |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 60.22 |
| Support Level | $3.26 | $23.51 |
| Resistance Level | $6.05 | $39.74 |
| Average True Range (ATR) | 0.53 | 1.05 |
| MACD | 0.05 | 0.37 |
| Stochastic Oscillator | 45.70 | 91.19 |
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.